Who
Michael Halpin
Chief Operating Officer
Company insider
Files Form 4 as: Chief Operating Officer, Vericel.
In numbers
- Trades disclosed
- 163
- Buys
- 0
- Sells
- 16
- Bought
- $0
- Sold
- $8.8M
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 11 Nov 2019
- Last trade
- 3 Aug 2026
- Last filed
- 5 Aug 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 3 Aug 2026filed 5 Aug 2026 | VCEL VericelBiotechnology | SEC FORM 4 Code M | $167K10,000 at $16.66 | filing |
| 3 Aug 2026filed 5 Aug 2026 | VCEL VericelBiotechnology | SEC FORM 4 Sold | $468K10,000 at $46.84 | filing |
| 3 Aug 2026filed 5 Aug 2026 | VCEL Vericeloption or derivative · Biotechnology | SEC FORM 4 Code M | —10,000 at $0.00 | filing |
| 3 Aug 2026filed 5 Aug 2026 | VCEL Vericeloption or derivative · Biotechnology | SEC FORM 4 Code M | —10,000 at $0.00 | filing |
| 3 Aug 2026filed 5 Aug 2026 | VCEL VericelBiotechnology | SEC FORM 4 Code M | $167K10,000 at $16.66 | filing |
| 3 Aug 2026filed 5 Aug 2026 | VCEL VericelBiotechnology | SEC FORM 4 Sold | $468K10,000 at $46.84 | filing |
| 18 Jun 2026filed 22 Jun 2026 | VCEL VericelBiotechnology | SEC FORM 4 Code M | $167K10,000 at $16.66 | filing |
| 18 Jun 2026filed 22 Jun 2026 | VCEL VericelBiotechnology | SEC FORM 4 Sold | $402K10,000 at $40.24 | filing |
| 18 Jun 2026filed 22 Jun 2026 | VCEL Vericeloption or derivative · Biotechnology | SEC FORM 4 Code M | —10,000 at $0.00 | filing |
| 18 Jun 2026filed 22 Jun 2026 | VCEL Vericeloption or derivative · Biotechnology | SEC FORM 4 Code M | —10,000 at $0.00 | filing |
| 18 Jun 2026filed 22 Jun 2026 | VCEL VericelBiotechnology | SEC FORM 4 Code M | $167K10,000 at $16.66 | filing |
| 18 Jun 2026filed 22 Jun 2026 | VCEL VericelBiotechnology | SEC FORM 4 Sold | $402K10,000 at $40.24 | filing |
| 2 Mar 2026filed 4 Mar 2026 | VCEL VericelBiotechnology | SEC FORM 4 Sold | $364K10,305 at $35.30 | filing |
| 2 Mar 2026filed 4 Mar 2026 | VCEL VericelBiotechnology | SEC FORM 4 Sold | $364K10,305 at $35.30 | filing |
| 24 Feb 2026filed 26 Feb 2026 | VCEL VericelBiotechnology | SEC FORM 4 Code M | —5,250 at $0.00 | filing |
| 24 Feb 2026filed 26 Feb 2026 | VCEL VericelBiotechnology | SEC FORM 4 Code F | $95K2,486 at $38.09 | filing |
| 24 Feb 2026filed 26 Feb 2026 | VCEL VericelBiotechnology | SEC FORM 4 Code M | —5,250 at $0.00 | filing |
| 24 Feb 2026filed 26 Feb 2026 | VCEL Vericeloption or derivative · Biotechnology | SEC FORM 4 Code M | —5,250 | filing |
| 24 Feb 2026filed 26 Feb 2026 | VCEL Vericeloption or derivative · Biotechnology | SEC FORM 4 Code M | —5,250 | filing |
| 24 Feb 2026filed 26 Feb 2026 | VCEL VericelBiotechnology | SEC FORM 4 Code F | $95K2,486 at $38.25 | filing |
News
No headline names them, or the companies they trade most, lately.